The use of a computer program to calculate the mean amplitude of glycemic excursions

Diabetes Technology and Therapeutics

Volumn 13, Issue 3, 2011, Pages 319-325

  Fritzsche, Gert ^a   Kohnert, Klaus Dieter ^b   Heinke, Peter ^b   Vogt, Lutz ^a   Salzsieder, Eckhard ^b  

^a Diabetes Service Center   (Germany)

^b Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS SOFTWARE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ALGORITHMS; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79952143101     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0108     Document Type: Article

References (17)

1. Hirsch IB, Brownlee M: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2007;30:186-187. (Pubitemid 46052530)
2. Bragd J, Adamson U, Baecklund LB, Lins PE, Moberg E, Oskarsson P: Can glycemic variability, as calculated form blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008;34:612-616.
3. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Guigliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress thanmean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-1354.
4. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
5. White NH, Chase HP, Arslanian S, Tamborlane V: A comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as a basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care 2009;32:387-393.
6. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Del Prato S, Tiengo A, Buhr A, Trevisan R, Bartussio A: In type 1 diabetic patients with good glycemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25:326-332. (Pubitemid 351322703)
7. Zhou J, Jia W, Bao Y, Ma X, Lu W, Li H, Hu, C, Xiang K: Glycemic variability and its response to intensive insulin treatment in newly diagnosed type 2 diabetes. Med Sci Monit 2008;14:CR552-CR558.
8. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonardt W, Fuecker K, Hanefeld M: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose and HbA1c level. Diabetes Care 2000;23:1830-1834.
9. Monnier C, Colette C, Owens DR: Glycemic variability: the third component of dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008;2:1094-1100.
10. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19: 644-655.
11. Service FJ, Nelson RL: Characteristics of glycemic stability. Diabetes Care 1980;3:58-62. (Pubitemid 10079157)
12. Kohnert KD, Vogt L, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, Salzsieder E: Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes. Horm Metab Res 2009;41:137-141.
13. Rodbard D: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009;11:551-565.
14. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160. (Pubitemid 29425900)
15. Zaccardi F, Di Stefano P, Busett E, Federici MO, Manto A, Infusino F, Lanza GA, Pitocco D, Ghirlanda G: Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol 2008,2:1061-1065.
16. Rodbard D, Jovanovic L, Garg SK: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther 2009;11:757-765.
17. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witt DR; ADAG Study Group: Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes 2010;59:1585-1590.